Healthcare & Life Sciences
Janux Therapeutics
United Stateswww.januxrx.com/
Janux Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
activeseries-b
series-b
Stage
2
Investors
About Janux Therapeutics
Janux Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Janux Therapeutics is a clinical-stage biotechnology company developing precision-engineered T cell immunotherapies for cancer and autoimmune diseases using its proprietary TRACTr, TRACIr and ARM technology platforms to generate targeted and durable immune responses while limiting systemic toxicity.
Explore Janux Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.